FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

ICH Draft Q&A Guide on DNA Reactive Impurities

FDA posts an International Council for Harmonization draft guidance entitled M7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharm...

FDA General

Since Our Last Issue ...

Industry news you may have missed since our last issue.

Biologics

Vaccines Panel Chair Recuses Herself Over Conflict

FDA vaccines advisory committee chair Hana El Sahly recuses herself from reviewing any upcoming pandemic vaccines because of her role overseeing a Mod...

Medical Devices

First Serology Covid Point-of-Care Test Authorized

FDA issues Assure Tech an emergency use authorization for the first serology (antibody) point-of-care test for Covid-19.

Human Drugs

BMS Reports Opdivo Positive Data in Urothelial Carcinoma

Bristol Myers Squibb says an Opdivo (nivolumab) Phase 3 trial in patients post-surgery with high-risk, muscle-invasive urothelial carcinoma met its pr...

Federal Register

3 Guidances for Conformity Assessment Pilot Program

Federal Register notice: FDA makes available three final guidance documents for its Accreditation Scheme for Conformity Assessment Pilot Program.

Human Drugs

Vertex Pharmas Kalydeco Gains Expanded Indication

FDA approves Vertex Pharmaceuticals Kalydeco (ivacaftor) for use in certain children with cystic fibrosis ages four months to less than six months old...

Human Drugs

FDA OKs Glaxos Nucala for Hypereosinophilic Syndrome

FDA approves GlaxoSmithKlines Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome for six months or l...

Human Drugs

RemeGen Breakthrough Status for Disitamab Vedotin

FDA grants RemeGen a Breakthrough Therapy designation for disitamab vedotin (RC48), an anti-HER2 antibody drug conjugate for second-line treatment of ...

Medical Devices

3 Device Accreditation Guidances Issued

FDA publishes three guidances implementing the voluntary pilot for the Accreditation Scheme for Conformity Assessment.